Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægen Bjergegade 3 ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5%   Bankruptcy risk   6.4% 5.4% 7.3% 7.9% 11.0% 6.5% 21.2% 19.2%   Credit score (0-100)   39 43 34 31 21 36 4 7   Credit rating   BBB BBB BBB BB BB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,158 1,222 1,251 1,330 1,014 1,386 0.0 0.0   EBITDA   175 310 291 235 117 242 0.0 0.0   EBIT   -23.8 105 67.9 54.9 -44.7 198 0.0 0.0   Pre-tax profit (PTP)   -58.7 69.2 54.4 13.4 -56.6 185.3 0.0 0.0   Net earnings   -55.5 52.9 42.0 5.1 -62.8 139.2 0.0 0.0   Pre-tax profit without non-rec. items   -58.7 69.2 54.4 13.4 -56.6 185 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   124 191 111 73.8 55.4 11.2 0.0 0.0   Shareholders equity total   -29.4 23.5 65.5 70.6 7.8 147 22.1 22.1   Interest-bearing liabilities   580 549 239 67.9 113 26.6 0.0 0.0   Balance sheet total (assets)   933 873 623 576 362 357 22.1 22.1   Net Debt   578 548 163 -128 92.7 -193 -22.1 -22.1     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,158 1,222 1,251 1,330 1,014 1,386 0.0 0.0   Gross profit growth   -10.4% 5.5% 2.3% 6.3% -23.8% 36.7% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   933 873 623 576 362 357 22 22   Balance sheet change%   -12.1% -6.4% -28.7% -7.6% -37.2% -1.2% -93.8% 0.0%   Added value   174.6 310.0 291.0 234.9 135.3 242.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -362 -280 -446 -360 -323 -88 -11 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -2.1% 8.6% 5.4% 4.1% -4.4% 14.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -1.9% 11.9% 9.7% 9.6% -9.0% 56.2% 0.0% 0.0%   ROI %   -3.1% 19.0% 16.5% 25.4% -31.7% 137.5% 0.0% 0.0%   ROE %   -11.6% 11.1% 94.3% 7.5% -160.2% 179.8% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   -3.1% 2.7% 10.5% 12.3% 2.2% 41.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   331.3% 176.8% 56.0% -54.5% 79.5% -79.6% 0.0% 0.0%   Gearing %   -1,974.5% 2,334.5% 365.3% 96.2% 1,441.9% 18.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.6% 7.2% 4.6% 28.6% 15.9% 24.2% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   0.2 0.3 0.4 0.6 0.7 1.8 0.0 0.0   Current Ratio   0.3 0.4 0.5 0.7 0.9 2.1 0.0 0.0   Cash and cash equivalent   1.1 0.8 76.3 195.9 19.8 219.6 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -534.3 -379.5 -253.3 -123.1 -48.9 169.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   87 155 146 117 68 121 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   87 155 146 117 58 121 0 0   EBIT / employee   -12 52 34 27 -22 99 0 0   Net earnings / employee   -28 26 21 3 -31 70 0 0